title: Recurrent PNET with MGMT methylation responds to temozolomide.
authors.affiliation: Divison of Neurology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
authors.forename: Jiwon
authors.initials: J
authors.lastname: Oh
authors.forename: Juan M
authors.initials: JM
authors.lastname: Bilbao
authors.forename: May N
authors.initials: MN
authors.lastname: Tsao
authors.forename: Mahmood
authors.initials: M
authors.lastname: Fazl
authors.forename: Marie-Christine
authors.initials: MC
authors.lastname: Guiot
authors.forename: Rolando F
authors.initials: RF
authors.lastname: Del Maestro
authors.forename: James R
authors.initials: JR
authors.lastname: Perry
mesh_terms: D000328:Adult; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics*; D003606:Dacarbazine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008745:Methylation; D018242:Neuroectodermal Tumors, Primitive / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics*; D019853:O(6)-Methylguanine-DNA Methyltransferase / Q000235:genetics; D000077204:Temozolomide
chemical_list: D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine; D019853:O(6)-Methylguanine-DNA Methyltransferase; D000077204:Temozolomide